BECRO Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Athens Greece (2010)

Organization Overview

First Clinical Trial
2018
NCT03751202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Becro Ltd. | BECRO Ltd.